Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Pleural Effusion, Malignant 3Pleural Effusion 1Pleural Diseases 1Lung Neoplasms 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Chest Tubes × Thoracic × Clear all
NCT03973957 2019-06-04

TOPIC

The Cooper Health System

Phase NA Unknown
124 enrolled
Thoracic

Pleural Diseases, Pleural Effusion, Pleural Effusion, Malignant

NCT03319186 2017-10-24

Pre-EDIT

NHS Greater Glasgow and Clyde

Phase NA Unknown
30 enrolled
Thoracic

Pleural Effusion, Malignant

NCT02825095 2016-07-07

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Rambam Health Care Campus

Phase EARLY_PHASE1 Unknown
120 enrolled
Thoracic

Lung Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡